Bernstein reinstates coverage on Regeneron Pharma (NASDAQ: REGN) with a Market Perform rating and a price target of $309.00.

For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.

Shares of Regeneron Pharma closed at $300.77 yesterday.